The aim of these studies was to synthesize, characterize and evaluate the efficacy of pegylated gold nanoparticles (AuNPs) that differed in their PEG molecular weight, using PEG 550 and PEG 2000.
The synthesis of the gold nanoparticles was carried out by modified Brust method with a diameter of 4-15nm. The targeting agent folic acid was introduced by the covalent linkage. Finally, the anti-cancer drug docetaxel was encapsulated by the AuNPs by non covalent adsorption. The nanoparticles were characterized by transmission electron microscopy and used for in vitro studies against a hormone-responsive prostate cancer cell line, LnCaP. The loaded nanoparticles reduced the cell viability in more than 50% at concentrations of 6nM and above after 144h of treatment. Moreover, observation of prostate cancer cells by optical microscopy showed damage to the cells after exposure to drug-loaded AuNPs while unloaded AuNPs had much less effect.
Written by:
de Oliveira R, Zhao P, Li N, de Santa Maria LC, Vergnaud J, Ruiz J, Astruc D, Barratt G. Are you the author?
Universidade do Estado do Rio de Janeiro, Instituto de Química, Brazil; Insitut Galien Paris-Sud, UMR CNRS 8612, Faculté de Pharmacie, Univ. Paris-Sud, LabEx LERMIT, Châtenay-Malabry, France.
Reference: Int J Pharm. 2013 May 21. pii: S0378-5173(13)00434-1.
doi: 10.1016/j.ijpharm.2013.05.031
PubMed Abstract
PMID: 23701998
UroToday.com Investigative Urology Section
